Living In The Future with Niall Murphy Niall Murphy

Tasmanian Daniel Faber is the founder & CEO of OrbitFab, focused on solving a very important problem - how to refuel satellites and other assets in space. Up to now everything put into orbit ultimately becomes space junk. A propellant supply chain in space is a critical enabler to a dynamic space economy.

Daniel is an engineer and entrepreneur with over 25 years in space technology. His goal is to create permanent jobs in space. OrbitFab has tens of millions in contracts to deliver propellant in Earth orbit, from commercial and government customers. Daniel is the former CEO of Deep Space Industries and has worked as an engineer on technology ranging from satellites, rockets and nuclear fusion reactors to coal power stations and steel mills.

Emil and I met in October during a discussion on longevity in Berlin. In this discussion we explore his work on human cryopreservation and the role the technology might play in helping people time travel to a future where critical ailments might have remedy. Futuristic stuff indeed, but this is actually happening. Emil and his colleagues already have a number of people in cryopreservation, and the European Biostasis Foundation in Switzerland he directs is very serious about its mission.  

Dr. Emil Kendziorra is a medical doctor by training and former cancer researcher. He spent the 10 years as a tech entrepreneur, with two successful exits. Now Emil leads Tomorrow Bio, a biostasis bio tech business, and a non-profit research institute in Switzerland called the European Biostasis Foundation focused on cryopreservation research.

Mark Kotter is at the forefront of transitioning biology to engineering. He is a doctor, scientist and serial entrepreneur. Mark’s work is addressing many of the most important human needs, including cancer and the consequences of poor health due to ageing.
His company Bit.bio made an important announcement earlier this year with the launch of a powerful new toolset for programming STEM cells. It’s hard to overstate the implications of this technology, and the pathways it suggests for regeneration and repairing organs in the human body, enhancement with new cells, and growing or printing new organs.
Mark is the founder of Bit.bio, co-founder of cultured meat startup Meatable, anti-ageing start-up Clock.bio, and co-founder and trustee of spinal cord injury charity Myelopathy.org.

Dani Clode is Head Designer & Senior Technical Specialist at the Plasticity Lab at Cambridge University. She is best known for developing a second thumb that can be added to your hand and that you control with your toes. In this podcast we discuss what body augmentation means, societal acceptance, and the challenges and constraints of progressing it.

Dominik Schiener is co-founder of blockchain distributed ledger IOTA and a man on a mission to automate trust on the internet. In this wide ranging conversation we explore why this trust infrastructure is important, what it might enable, and what some of the issues are in realising this future.